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Summary 
Ehlers-Danlos syndrome (EDS) is a group of heritable connective tissue disorders caused by 
defective collagen synthesis or incorrect assembly of the collagen triple helical structure. EDS 
is characterised by joint hypermobility, skin hyperextensibility, abnormal scarring, poor wound 
healing and tissue friability. Human EDS may be caused by variants in several different genes 
including COL5A1, which encodes the collagen type V alpha 1 chain. For the present study 
we investigated a 1.5-year-old, spayed female, domestic shorthair cat with EDS. The affected 
cat showed multiple recurrent skin tears, hyperextensibility of the skin and joint abnormalities. 
We obtained whole genome sequencing data from the affected cat and searched for variants 
in candidate genes known to cause EDS. We detected a heterozygous single-base pair 
deletion in exon 43 of the COL5A1 gene, c.3420delG. The deletion was predicted to result in 
a frameshift and premature stop codon, p.(Leu1141SerfsTer134). Sanger sequencing 
confirmed that the variant was present in the affected cat and absent from 103 unaffected cats 
from different breeds. The variant was also absent from a Burmese cat with EDS. Based on 
knowledge of the functional impact of COL5A1 variants in other species, COL5A1:c.3420delG 
represents a compelling candidate causative variant for the observed EDS in the affected cat. 
 
 
 
 
Keywords: felis catus, skin, dermatology, collagen, genodermatosis, whole genome 
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Ehlers-Danlos syndrome (EDS) is a clinically and genetically heterogeneous group of heritable 
connective tissue disorders. EDS is caused by defective collagen synthesis or incorrect 
assembly of the collagen triple helical structure. The phenotype is characterised by joint 
hypermobility, skin hyperextensibility, abnormal scarring, poor wound healing and tissue 
friability (Byers & Murray 2012; De Paepe & Malfait 2012). Collagen provides the connective 
tissue matrix with shape, strength and the ability to resist deformation, thus being a key 
structural protein of the connective tissue. Fibrillary collagen proteins consist of three either 
homo- or heterotrimeric polypeptide chains, designated as α-chains, which together form a 
triple helical structure (De Paepe & Malfait 2012). As a result of defects in fibrillary collagen, 
the skin may become more fragile and tear more easily. 
According to the 2017 international classification there are 13 recognized subtypes of EDS in 
humans. Depending on the causative variant, EDS may follow an autosomal dominant or 
autosomal recessive mode of inheritance (Malfait et al. 2017). 
The most common type of EDS, the so called classical EDS (cEDS), formerly categorized as 
EDS I or EDS II, is caused by genetic variants in the COL5A1 and COL5A2 genes (Nicholls et 
al. 1996; Symoens et al. 2008; Malfait et al. 2010; Bowen et al. 2017). Variants in many other 
genes are known to have an impact on collagen structure, which may also result in the clinical 
picture of EDS (Byers & Murray 2012; De Paepe & Malfait 2012; Malfait et al. 2017). 
Connective tissue diseases resembling human EDS were observed in many different 
mammalian species such as e.g. cattle, dogs, minks, horses, rabbits, and sheep (Hegreberg 
et al. 1969; Harvey et al. 1990; Colige et al. 1999; Sequeira et al. 1999; Paciello et al. 2003; 
Zhou et al. 2012; Monthoux et al. 2015). A closely related phenotype is the equine regional 
dermal asthenia (HERDA) in horses, which is caused by a variant in the PPIB gene (Tryon et 
al. 2007). Furthermore, a Holstein calf with a phenotype described as variant form of EDS and 
a heterozygous missense variant in the EPYC was reported (Tajima et al. 1999). This calf had 
a deficiency of dermatan sulfate proteoglycan, but the causality of the EPYC genetic variant 
was not conclusively proven. So far, neither PPIB nor EPYC variants were reported in human 
EDS patients. 
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In cats, isolated EDS cases have been described as cutaneous asthenia or dermatosparaxis 
in several individual purebred and crossbred animals (OMIA 000327-9685; Scott, 1974; 
Patterson & Minor 1977; Counts et al. 1980; Holbrook et al. 1980; Verweij & van Zuylen 1986; 
Plotnick et al. 1992; Sequeira et al. 1999; Benitah et al. 2004; Smids, 2008; Dokuzeylül et al. 
2013; Weingart et al. 2014). An experimental domestic shorthair cat colony with an autosomal 
dominant form of EDS was established to study the biomechanical properties and would 
healing characteristics of skin (Freeman et al. 1989a; Freeman et al. 1989b). More recently, 
EDS has also been observed in several Burmese cats and it was suggested that an autosomal 
recessive form of EDS may be segregating in this breed (Hansen et al. 2015). 
Before genetic analyses became widely available, a detailed biochemical analysis in a single 
affected Himalayan cat revealed a defect in ADAMTS2, the procollagen N-endopeptidase 
(Counts et al. 1980). Thus, this case corresponded to the human dermatosparaxis EDS (dEDS 
or formerly EDS VIIC). To the best of our knowledge, no causative genetic variant in a cat with 
EDS has yet been reported in the scientific literature. 
In the present study, we investigated a 1.5-year-old, spayed female domestic shorthair cat with 
characteristics of EDS. The affected cat showed multiple recurrent skin tears with little or no 
bleeding, mainly located on the dorsal neck and the shoulders, and hyperextensibility of the 
skin (Figure 1). The skin extensibility index according to Hansen et al. 2015 was 27%. Some 
of the previous lacerations had slowly healed leaving shiny alopecic scars. Other clinical 
findings included bilateral hip subluxation with positive Ortolani sign even in the awake patient, 
bilateral carpal hyperextension with plantigrade appearance, pain and laxity during palpation 
of all joints, and bilateral perineal hernias. The index cat was found on the street when she 
was a kitten, together with a female littermate, which appeared to be normal at the clinical 
examination. Information about the parents was not available. 
To confirm our hypothesis of a genetic defect related to collagen, we obtained an EDTA blood 
sample of the affected cat, isolated genomic DNA, and performed whole genome re-
sequencing at 20x coverage using 2 x 150 bp reads on an illumina HiSeq 3000 instrument. 
Private variants were identified by comparing the sequence from the affected cat to the feline 
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reference genome assembly FelCat 9.0 and to genome re-sequencing data from 11 genetically 
diverse control cats obtained during other projects (database accessions given in Table S1). 
The methodology was previously described (Bauer et al. 2017). We identified 93 private 
homozygous and 2339 private heterozygous protein-changing variants (Table S2). These 
variants included a heterozygous frameshifting single-base deletion in exon 43 of the COL5A1 
gene (XM_023242950.1:c.3420delG or Chr13:93,210,344delC or 
XP_023098718.1:p.(Leu1141SerfsTer134)). None of the other private protein-changing 
variants were located in a known EDS candidate gene. 
We confirmed the COL5A1:c.3420delG variant in the affected cat using Sanger sequencing 
and genotyped a sample of 104 genetically diverse cats including the unaffected littermate of 
the affected cat and a Burmese cat affected by EDS. Primers COL5A1_F1, 
AAGCTGGCTGAAACCCATC and COL5A1_R1, CGAGCACTCCAGAGATGTCA, were used 
to amplify a 418 bp amplicon containing the COL5A1:c.3420delG variant. Both primers were 
individually used as sequencing primers to obtain sequences in both orientations on an ABI 
3730 capillary sequencer. This experiment confirmed that the variant was exclusively present 
in the affected cat and did not occur in the other 104 genotyped cats including the Burmese 
cat with EDS (Figure 2). 
The identified COL5A1:c.3420delG variant in the affected cat causes a shift in the open reading 
frame resulting in a premature stop codon and is predicted to truncate approximately one third 
of the 1837 amino acids of the wildtype COL5A1 protein. The human and feline proteins share 
96% amino acid identity. Heterozygous variants in the COL5A1 gene may cause EDS in 
humans and mice (Wenstrup et al. 2006; Malfait et al. 2017). In human EDS patients, many 
COL5A1 nonsense, frameshift or splice site variants were reported (Symoens et al. 2008; 
Malfait et al. 2010; Byers & Murray 2012). The ClinVar database lists human pathogenic 
COL5A1 frameshift variants, which are comparable to the identified feline variant and lead to 
relatively mild clinical forms of cEDS (formerly EDS II), e.g. NM_001278074.1:c.3206dup 
(p.Ala1070Serfs) and NM_000093.4:c.3752delC (p.Pro1251Argfs). The knowledge on the 
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functional impact of COL5A1 frameshift variants in humans suggests a causal role for the 
detected feline COL5A1:c.3420delG variant in the cat with EDS. 
As we did not have access to RNA or protein samples from the affected cat, we could not 
investigate the functional consequences of the genomic variant. It seems likely that transcripts 
from the mutant allele are degraded by nonsense mediated decay or other quality control 
mechanisms, which might lead to a reduced amount of synthesized collagen type V alpha 1 
chains and cause the clinical phenotype due to haploinsufficiency, similar to what has been 
observed in Col5a1+/- mice (Wenstrup et al. 2006). An alternative pathomechanism, in which 
at least some of the mutant protein is expressed and incorporated into defective collagen triple 
helices can also not be ruled out. The triple-helical structure of collagen makes it particularly 
sensitive to genetic variants as each mutant protein molecule can potentially oligomerize with 
up to two wildtype protein molecules, thereby exerting a pronounced dominant negative effect. 
No information on the parents of the affected cat was available. It is therefore impossible to 
investigate whether the COL5A1:c.3420delG variant was due to a de novo mutation event or 
whether it was actually transmitted by one of the cat’s parents. Given the autosomal dominant 
mode of inheritance, we speculate that this variant is probably limited to the observed case. 
In summary, we identified a heterozygous single nucleotide deletion in COL5A1 in a cat with 
EDS. The variant was not present in 103 unaffected control cats or a Burmese cat with EDS. 
The known functional impact of COL5A1 frameshift variants in humans suggest that the 
detected feline COL5A1:c.3420delG variant is an excellent candidate causative variant for the 
EDS phenotype in the investigated cat. 
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Figure 1. Ehlers-Danlos syndrome in a cat. (A) Skin tear on the right shoulder. (B) Hyperextensibility of 
the skin. 
 
 
 
 
 
Figure 2. Electropherograms showing the COL5A1:c.3420delG frameshift variant. (A) Wildtype 
sequence of an unaffected cat. (B) Mutant sequence in the affected cat. The heterozygous deletion of 
a single guanine leading to a frameshift is indicated by an arrow. Wildtype sequences are shown in 
black, mutant sequences in red. 
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